Two peptide sellers can carry almost the same catalog, run similar monthly volume, and still end up with completely different payment accounts. One gets approved in a week, runs at a 5% reserve, and pays rates in the mid-3% range. The other waits a month for approval, watches 10% of every deposit sit in a reserve, and gets closed on a review 90 days in.
The gap usually comes down to a decision made before either of them processed a dollar: which compliant path the account was underwritten for. There are two of them, and they are not interchangeable.
When a peptide seller starts shopping for processing, the first question is almost always who will approve me, and how fast. That is the wrong place to start. The two legitimate paths are research-use-only and LegitScript certification, and the sellers who stay online for years are the ones who first work out which one matches how they actually sell, then find a processor who underwrites that path on purpose.
Two compliant ways to sell peptides
Almost every legitimate peptide business falls into one of two models. They look similar from the outside and they are treated very differently by banks and card brands.
Research-use-only
Research-use-only, or RUO, means you sell peptides as laboratory reagents for research, not for people to take. Structured properly, an RUO business sits outside the drug framework entirely. That means selling to verified research accounts, keeping therapeutic claims off your site and your labels, and holding documentation that backs up what you sell. Accounts like these are usually underwritten under merchant category code 8099, the code for medical services not classified elsewhere.
RUO is a real, compliant path, and it does not require LegitScript certification. What it does require is discipline about how you present the product. The moment an RUO site starts talking about dosing, weight loss, or anything that reads as advice for a human rather than a lab, it stops looking like research and starts looking like an unlicensed pharmacy. That is when the scrutiny arrives.
Prescription, telehealth, and clinical
The other path covers peptides sold for people to use, through a prescriber, a telehealth platform, or a compounding pharmacy operating under Section 503A of the federal drug law. This is a legitimate model too, with patient-specific prescriptions and real sterility standards behind it.
For this path, LegitScript certification has moved from optional to effectively mandatory. The major card networks now require it for telehealth, peptide, and hormone-therapy merchants, and an account without it is exposed to suspension at almost any time. If you sell peptides for human use, certification is the cost of staying online.
The two paths suit different businesses. The whole game is matching the path to how you actually sell.
What LegitScript certification actually involves
Certification is not a badge you buy once and forget. LegitScript reviews your website, your products, your policies, and your marketing, then keeps monitoring you after you pass. That ongoing oversight is the reason banks trust it. A certified merchant is being watched by someone other than the bank.
It carries a real cost and a real timeline. LegitScript raised its own certification fee from $500 to $950 and added per-transaction pricing on top, about $0.10 per transaction plus roughly 0.10% of volume. Getting certified usually takes two to four weeks, and longer if your site needs significant changes before it passes. None of that is a reason to avoid it. It is a reason to start early, before your current account becomes a problem.
What the path changes about your account
Once you know which path you are on, the economics follow. Across the peptide accounts we underwrite, a LegitScript-certified account and an uncertified one look very different from the first day:
| What it changes | LegitScript-certified | Uncertified |
|---|---|---|
| Approval time | About 5–7 business days — most of the compliance review is already done | 2–4 weeks while the bank runs that review itself |
| Reserve | 0–5%, and established merchants sometimes none | 10% or more of your volume held back |
| Processing rate | Sub 5% | Greater than 5% |
| Account stability | Hard to close on a whim once a bank underwrote you correctly | Approved fast, reviewed later — and closable on that review |
On $50,000 a month, the difference between a 10% reserve and a 5% one is $2,500 of your own cash freed up every month. The rate difference stacks on top of that.
The trap in the middle
Last month we wrote about peptide sellers who get approved quickly and then frozen months later. The mechanism behind a lot of those shutdowns lives right here, in the gap between the two paths.
To push a merchant through fast, some processors assign a category code that does not match what the business actually sells, or wave a human-use seller through without the certification that model now requires. It works until someone looks closely. When a card brand catches a miscoded account, the result can be termination and a listing on the Mastercard MATCH file, the industry blacklist that makes getting a new account far harder. A fast yes that puts you on MATCH a year later is the most expensive approval in this business, which is why underwriting for the right path is really part of compliance navigation, not a box to tick after the fact.
How to tell which path is yours
You usually already know, even if nobody has framed it for you this way:
- If you sell strictly to researchers and labs, keep all human-use language off your site, and can document it, the research-use-only path fits, and research-only peptide payment processing is built for exactly that.
- If a prescriber, a telehealth flow, or a compounding pharmacy is anywhere in your model, you are on the clinical path, and LegitScript certification is not optional.
- If your site currently mixes the two, that is the real risk, and it needs sorting out before you apply anywhere. Cleaning up product wording and labeling is often the difference between an easy approval and a violation notice.
The regulatory picture is still moving, which makes the choice matter even more right now. The FDA still lists 19 of the most-discussed peptides in its Category 2 bucket, and an FDA advisory committee recently recommended that four of them — BPC-157, TB-500, KPV, and MOTS-c — move forward. It is worth being precise about what that means. A recommendation is not approval: the committee is saying these peptides should be considered, not that they are legal or FDA-approved, and the FDA still has to make the final call. Building an account on a reclassification that has not happened yet is a bad bet, so underwrite for the rules as they stand today.
Questions we hear a lot
Do I need LegitScript certification to sell peptides?
Not always. If you run a genuine research-use-only operation and keep human-use claims off your site, you can process without it. If you sell for human use through any prescriber or telehealth model, certification is effectively required now.
How long does certification take?
Usually a few weeks for a clean site, and longer if products, policies, or marketing need to change before you pass. Because LegitScript keeps monitoring you afterward, it is worth doing properly rather than quickly.
Will certification actually lower my costs?
Generally, yes. Certified peptide accounts tend to carry lower reserves and land at the lower end of high-risk processing rates, because the bank sees a merchant that someone else is actively monitoring. The certification fees are real, but the reserve and rate savings usually outweigh them at volume.
Can I switch paths later?
You can, though it is easier to start on the right one. Moving from an uncertified account to a certified setup, or correcting a miscoded account, goes more smoothly when a processor who handles chargeback management and underwriting for the niche plans the move with you.
The takeaway: There is no single best way to process peptides. There is the path that matches how you sell, and the path that does not. Research-use-only and LegitScript certification are both legitimate, and the sellers who stay online are the ones who choose honestly, get underwritten for that path on purpose, and fix the wording and labeling that trip accounts up before they ever apply. Start from how you actually sell, not from who says yes the fastest.
Not sure which peptide processing path fits your business, or worried your current account was set up on the wrong one? Mint Group underwrites research-only and LegitScript-certified peptide sellers for the path that matches their model. Learn more about our research-only peptide payment processing, or talk to our team.